Explore the comprehensive supporting global CRO services provided by Resolian.
Resolian’s dedicated specialists are committed to delivering a wide range of CRO services, either as standalone solutions or as part of a complete drug development package.
Reach out to us directly to learn more about Resolian’s comprehensive supporting CRO services.
Our bioanalysis, logistics, and sample management teams work together to provide an integrated service for global, multi-center clinical studies for our clients.
Data Management
Delivering comprehensive Data Management services using efficient and meticulous processes, coupled with state-of-the-art technologies to ensure your clinical trial data is managed with precision and accuracy.
Microsampling
Delivering specialized methods and workflows that leverage innovative microsampling technology at the pre-clinical, clinical, and bioanalytical levels.
Document Production
Our dedicated Document Production team delivers high-quality, eCTD conformant reports that meet regulatory standards and accelerate your path to submission.
Our Project Management team has extensive expertise in a wide range of study types and therapeutic areas, and will oversee every aspect of your study.
Statistics
Delivering you timely, high-quality statistical services, in accordance with regulatory requirements.
Sample Management
Our sample management kits provide all the materials necessary for accurate, efficient, and safe preparation, collection, and shipment of clinical samples from trial sites to bioanalytical laboratories.
Archiving
Offering GLP-compliant archiving solutions within an HVAC-controlled environment.
Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.
Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.
Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD.
Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.